Abstract
Methodology of determination of whether a target biological cell is cancerous based on measurement of the surface potential of such cell and comparing it with the measurement of the surface potential of a normal cell using multifractal analysis to characterize the time-averaged spatial fluctuations of the surface potential. Determinative increase of multifractality of the surface potential is indicative of the cancerous nature of the target cell. Multifractality in surface potential can also be used as a novel biomarker for novel drug delivery methods based on bioelectric activation.
| Original language | English |
|---|---|
| Patent number | WO2024216108A1 |
| State | Published - 2024 |